106232-36-4

Basic information

• Product Name: 4-nitroso-5-phenyl-1H-imidazole
• Synonyms: 1H-imidazole, 5-nitroso-4-phenyl-; 5-Nitroso-4-phenyl-1H-imidazole
• CAS NO: 106232-36-4
• Molecular Formula: C₉H₇N₃O
• Molecular Weight: 173.1714
• Mol File: 106232-36-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 472.8°C at 760 mmHg
• Flash Point: 239.7°C
• Density: 1.31g/cm³
• Vapor Pressure: 1.18E-08mmHg at 25°C
• Refractive Index: 1.664
• CAS DataBase Reference: 4-nitroso-5-phenyl-1H-imidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 4-nitroso-5-phenyl-1H-imidazole(106232-36-4)
• EPA Substance Registry System: 4-nitroso-5-phenyl-1H-imidazole(106232-36-4)

Safety Data

• Hazardous Substances Data: 106232-36-4(Hazardous Substances Data)

Upstream product

• 463-04-7 n-Amyl nitrite 
• 670-95-1 4-Phenylimidazole 

Downstream Products

• 111380-08-6 1-Methyl-5-nitroso-4-phenylimidazole 
• 30016-23-0 3-formylamino-4-phenylfurazan 
• 14953-63-0 1-methyl-4-phenyl-5-nitroimidazole 
• 1039984-25-2 1-methyl-4-phenyl-5-aminoimidazole 
• 30738-65-9 3-benzoyl-1,2,4-oxadiazole 
• 111380-09-7 1-methyl-4-nitroso-5-phenylimidazole 
• 107010-32-2 2-Methoxy-5-phenyl-2,3-dihydro-imidazol-4-one oxime 
• 101875-12-1 bis-([1,2,4]oxadiazol-3-yl-phenyl-methylene)-hydrazine 
• 98879-79-9 [1,2,4]oxadiazol-3-yl-phenyl-methanone hydrazone 
• 111328-06-4 5-phenyl-1⁽³⁾H-imidazol-4-ylamine 

Relevant articles and documents

RADICAL ANIONS OF NITROSOIMIDAZOLES: PUTATIVE INTERMEDIATES IN THE MECHANISM OF ACTION OF NITROIMIDAZOLE ANTIBIOTICS

The radical anions of 1-methyl-4-phenyl-5-nitrosoimidazole and 5-phenyl-4-nitrosoimidazole have been detected using temperature resolved e.s.r spectroscopic techniques and are proposed as putative intermediates in the oxidation of thiols to disulphides by the nitrosoimidazoles.

Antitumor Imidazotetrazines. 14. Synthesis and Antitumor Activity of 6- and 8-Ssubstituted Imidazo-1,2,3,5-tetrazinones and 8-Substituted Pyrazolo-1,2,3,5-tetrazinones

The systematic variation of the potent antitumor agent mitozolomide (1) is extended to cover alteration of substituents at position 6 and 8 and to change the imidazo-1,2,3,5-tetrazinone (6) skeleton to the isomeric pyrazolo-1,2,3,5-tetrazino